This page is in an archival section of the web site; the information may be outdated.
For current content, please visit UCSF Today at http://www.ucsf.edu/today/

UCSF logo

ArchivesCalendarCampus NotesCampus EyeLife StyleQuickLinksHelp ResourcesSearch

Daybreak home

Today's
Headlines

This Week's
News

Daybreak News Story
     

1st appeared 16 August 2000

Bangsberg Wins Research Development Award

Selected for his innovative outcomes research of the HIV-positive urban poor, David Bangsberg is one of 17 researchers to receive the Doris Duke Clinical Scientist Development Award.

Bangsberg, MD, MPH, assistant professor of medicine at UCSF, director of the Epidemiology and Prevention Interventions (EPI) Center at San Francisco General Hospital Medical Center, has focused his research on HIV infection in the urban indigent. In March, he served as the lead author on a preliminary study published in the journal AIDS that found that most HIV-positive people who are homeless or live in low-income hotels are able to stick to the demanding drug schedules required by combination anti-viral therapy. He is among the researchers that argue that the HIV-infected urban poor should have access to protease inhibitors and other new antiretroviral drugs.

Bangsberg earned his MD degree from Johns Hopkins University and MPH from UC Berkeley. He completed residency training in internal medicine at Columbia-Presbyterian Hospital in New York, where he was chief resident. He also served as a fellow in infectious disease at UCSF.

A native of Portland, Ore., he received his bachelor's of science degree in biology from the University of Rochester and a master's in the history and philosophy of science from Kings College, University of London.

The Doris Duke Charitable Foundation awarded a total of more than $9 million to recipients of the third annual Doris Duke Clinical Scientist Development Award and the inaugural Doris Duke Innovation in Clinical Research Award. The two award programs reflect the foundation's commitment to support clinical research, foster the career development of outstanding physician-scientists and encourage innovative research.

"It is an exceptional time for clinical research. As we begin the post-genomic era, the opportunities to treat and cure human diseases and to improve health are extraordinary," says Joan E. Spero, president of the Doris Duke Charitable Foundation (DDCF).

Junior physician-scientists working in four disease areas cardiovascular diseases, cancer, AIDS and sickle cell anemia and other blood diseases were eligible to be nominated by academic medical centers and independent research institutions nationwide. Since it began in 1998, the award has committed more than $22 million to 44 physician-scientists beginning their careers in independent clinical research.

Doris Duke, who died in 1993, left her fortune to the Doris Duke Charitable Foundation. DDCF's mission is to improve the quality of people's lives by nurturing the arts, protecting the environment and seeking cures for diseases.

Those interested in receiving email notification of the next award competitions are invited to join the Medical Research Program's list-serve.

Links:

The Doris Duke Charitable website

For abstracts for all grantee projects, go to the Medical Research Program's website


DAYBREAK | ARCHIVES | CALENDAR | CAMPUS NOTES
CAMPUS EYE | LIFESTYLE | QUICK LINKS | HELP/RESOURCES | SEARCH

Copyright ©2000 Regents of the University of California. All rights reserved.
Please direct all comments and questions to the Daybreak Editor .
Please contact the UCSF Web Developer for questions of a technical nature.

New contact address: today@pubaff.ucsf.edu